International Journal of Current Research and Review
ISSN: 2231-2196 (Print)ISSN: 0975-5241 (Online)
Bootstrap Slider

Indexed and Abstracted in: Crossref, CAS Abstracts, Publons, Google Scholar, Open J-Gate, ROAD, Indian Citation Index (ICI), ResearchGATE, Ulrich's Periodicals Directory, WorldCat (World's largest network of library content and services)

Search Articles

Track manuscript

Full Html

IJCRR - Vol 13 Issue 13, July, 2021

Pages: 45-55

Date of Publication: 05-Jul-2021

Print Article   Download XML  Download PDF

Synthesis, Characterization, In-Vitro Antimicrobial Evaluation and Molecular Docking Studies of Aromatic Aldehydes Substituted Thiosemicarbazide Quinoxaline Derivatives

Author: Bipin Bihari, Girendra Kumar Gautam, Akash Ved

Category: Healthcare

Abstract:Background: In the present research work a series of novel quinoxaline thiosemicarbazide derivatives were synthesized by substitution of some aromatic aldehydes and their antimicrobial evaluation against various microbial strains with molecular docking studies. Methods: Lead molecule (1E, 4E)-1-(7-chloro-3-isopropyl quinoxaline-2(1H)-ylidene) thiosemicarbazide was synthesized and condensed with various aromatic aldehydes to synthesize derivatives. All derivatives (Va-Vf) were characterized by IR., NMR & Mass spectroscopy. The synthesized derivatives were evaluated in vitro for antibacterial and antifungal activities using the agar dilution method. Molecular docking studies of the derivatives were performed against E.coli DNA gyrase B and topoisomerase IV to find out essential binding sites against target protein PDB: 1AJ6 and 1S14 respectively. Results: Compounds Vb, Vc, Ve&Vf exhibited potent antibacterial and antifungal activity. Compounds, Vb and Vc were found to exhibit more potent activity against Gram \?Ve, bacterial strains at MIC 0.19 µg/ml whereas compound Ve and Vf showed potent activity against Gram +Ve bacterial strains and fungal strains at MIC 0.19 µg/ml and 0.78 µg/ml respectively. The docking studies revealed that all the compounds exhibit extensive binding to the active pockets of E.coli DNA gyrase B and topoisomerase IV. The compound Vb and Ve exhibit interactive binding energy -8.0 and -8.3 Kcal/mole to the active pocket site of E.coli DNA gyrase and -8.2 and 7.9 Kcal/mole to the active pocket site of topoisomerase IV respectively. Conclusion: In terms of SAR study, it was revealed that the activity profile against microbial strains was altered with electronic effects like electron-withdrawing or donating substitutions in aromatic aldehydes substituted quinoxaline thiosemicarbazide derivatives.

Keywords: Antimicrobial, Aromatic aldehydes, E.coli DNA gyrase B, E.coli Topoisomerase IV, Quinoxaline, Thiosemicarbazide

Full Text:


Struggling for the development of an antimicrobial drug is a vital global issue due to the rapid development of resistance to currently used antimicrobial drugs, the emergence of new microbial infections and the existence of chronic microbial infections.1Bacteria may obtain resistance through a variety of mechanisms such as by spontaneous mutations or acquisition of genetic material from other resistant organisms or modifying binding sites or production of enzymes that inactivate antimicrobial agents or altering in outer membrane protein channel that the drugs require for cell entry.2

Quinoxaline and its derivatives are important nitrogen-containing benzo-hetero cyclic compounds.3 Substituted quinoxaline derivatives are extensively employed in the building blocks of various pharmacologically active compounds. They exhibit a broad range of pharmacological activities such as antibacterial4,5,6 antifungal7,8, antitubercular9, antimalarial 10,11, antileishmanial12, anticancer13,14 and antidepressant15,16. Also, quinoxaline derivatives reported for antioxidant17, antimycobacterial18, antithrombotic19 and topoisomerase inhibition activity.20

            Over the past few decades, an immense interest of researchers has been focused on thiosemicarbazide pharmacophore due to their wide range of synthetic and analytical applications and pharmacological activities21,22. Thiosemicarbazide derivatives were synthesized and studied for various pharmacological activities such as antiviral23,24, anticancer 25, antitumor26,27, antiamoebic28,29, antiproliferative30, antidiabetic[31], anti-HIV32, anti-tubercular activities33. Recently, many thiosemicarbazide derivatives were synthesized and studied for their antibacterial and antifungal activity.34,35,36,37

                    DNA gyrase and topoisomerase IV are essential enzymes that display crucial roles in biological processes of bacterial growth such as replication, transcription, recombination repair and chromatin remodeling.38,39Nitrogen containing heterocyclic may be potential antibacterial drugs that inhibit bacterial topoisomerases40such as triazoles41, quinolones42, oxazolopyridines, amino pyrazinamides and pyrazole.43In continuation of our search, it was found that certain thiosemicarbazide derivatives evaluated as inhibitors of DNA gyrase and topoisomerase II of S. aureus and E. coli.44,45

Based on the aforementioned facts, we decided to synthesize some novel quinoxaline hybrid thiosemicarbazide derivatives incorporated with different aromatic aldehydes through imine linkage in the thiosemicarbazide nucleus. All the synthesized compounds were screened in vitro for antibacterial and antifungal activities against various strains. In addition, to understand the mechanism of action and binding activity, molecular docking studies were performed against two kinases, E. coli DNA gyrase B and E. coli topoisomerase IV against target protein PDB: 1AJ6 and 1S14 respectively46,47. Computational studies were performed to analyze binding and orientation patterns of the ligands with amino acids against target protein (PDB: 1AJ6 and 1S14)


Materials and methods

All the reagents and the solvents used in the research work were of synthetic reagent grade and obtained from Qualigens Ltd. (Fisher Scientific), Ranbaxy, and Fine Chemicals Ltd. India. Muller-Hinton and Sabouraud dextrose agar were obtained from Hi-Media Ltd. India. The bacterial and fungal strains were provided by the Department of Biotechnology of Saroj Institute of Technology & Management, Lucknow, India.

The Progress of reactions and purity of derivatives were monitored by ascending thin layer chromatography on precoated silica gel-G sheets (E. Merck and Co.).Column chromatography was performed over silica gel (60-120 Mesh) obtained from QualigensTM(India). The percentage of yield, Rf values, melting points, and spectral analysis are given for various purified compounds. Yields are presented for crude products. Log P values for synthesized compounds were calculated by using Chem Draw Ultra 10.0.

Melting points were determined by using the Digital Elico melting point apparatus. Infra-red spectra were measured on a Perkin-Elmer FT-IR RXI Spectrophotometer. 1HNMR spectra were reported on a Bruker DPX-300 Spectrometer (300 MHz) using DMSO-D6 as a solvent and tetramethylsilane (TMS) as an internal reference standard. Electron Spinning Ionization Mass spectra (ESI-MS) were obtained on the JEOL SX 102 spectrometer. Elemental analysis was determined on an Elemental Vario EL-III elemental analyzer. The structure of molecules was confirmed based on spectral data.

A series of aromatic aldehydes substituted (1E, 4E)-1-(7-chloro-3-isopropyl quinoxaline-2(1H)-ylidene) thiosemicarbazide derivatives were synthesized according to the respective scheme (Figure 1).

Synthesis of 7-Chloro-3-isopropyl-1H-quinoxaline-2-one(III):

4-Chlorobenzene-1, 2-diamine (I) (21.3 g, 0.15 M) was dissolved in n-butanol (300 ml) and warmed. Ethyl dimethyl pyruvate (II) (21.6 g, 0.15 M) was solubilized separately in n-butanol (150 ml) and added to the former solution with constant stirring. The reaction mixture was refluxed for about 1 hour 30 minutes on the water bath. The reaction mixture was allowed to cool, obtained crystals, which were allowed for filtration, washed and purified by recrystallization from ethanol to obtain the white crystals of 7-chloro-3-isopropyl-1H-quinoxaline-2-one (III). The completion of the reaction and purity of the compound was checked by a single spot TLC.

Yield: 89.5%; m.p.225-228oC; Mol. Formula:C11H11ClN2O; Mol. Wt:222.67; IR (KBr, cm-1): 3465 (NH str.), 3102(C-H sp2 str.), 1659(C=N str.), 1605(C=C aromatic str.), 1372(CH (CH3)2str.). 1042(C-Cl str.), 1690(C=O str.); 1H- NMR(300 MHz, DMSO-d6) δ(ppm): 10.15(S, 1H, NH), 8.06(S, 1H, Ar. H), 7.25 -7.28(d, 1H, Ar. H), 6.97-7.05(d, 1H, Ar. H), 2.25-2.43(m, 1H, CH, i-pr.), 1.63(s, 6H, -(CH3)2); ESI-MASS: m/z[M+1]+223.19;Anal. Calculated for (C11H11ClN2O): C, 59.33; H, 4.98; N, 12.58;Found: C, 59.29; H, 5.02; N, 12.52.

Synthesis of (1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene) thiosemicarbazide(IV):

7-Chloro-3-isopropyl-1H-quinoxaline-2-one (III) (22 g, 0.10 M) was dissolved in ethanol (350 ml) and added thiosemicarbazide (9 g, 0.10 M). The reaction mixture was stirred and refluxed for 4 hours. The reaction mixture was allowed to cool at room temperature, obtained crystals. The crystals were collected by filtration, washed and purified by recrystallization from ethanol to yield white crystals of (1E, 4E)-1-(7-chloro-3-isopropyl quinoxaline-2(1H)-ylidene) thiosemicarbazide (IV). The completion of the reaction and purity of the compound was checked by a single spot TLC.

Yield: 85.5 %; m.p. 218--222 oC; Mol. Formula: C12H14ClN5S; Mol. Wt: 295.79; IR (KBr, cm-1): 3442(NH str.), 3066(C-H sp2 str.), 3002(N-H2str.), 1654(C=N str.), 1602(C=C aromatic str.), 1361(CH(CH3)2str.). 1037(C-Clstr.);1H-NMR(300MHz,DMSO-d6)δ(ppm):10.02(S,1H,NH),9.62(S,1H,NH),8.09(S,1H,Ar.H),7.26-7.34(d,1H,Ar.H),6.96-6.98(d,1H,Ar.H),4.99(S,2H,NH2),2.18-2.64(m,1H,CH,i-pr.),1.59(d,6H,-(CH3)2);ESI-MASS:m/z[M+1]+296.09;Anal.CalculatedforC12H14ClN5S:C,48.73;H,4.77;N,23.68;S,10.84;Found:C,48.69;H,4.72;N,23.74.

General procedure for the synthesis of a series of different aromatic aldehydes substituted quinoxalinethiosemicarbazide derivatives (Va -Vf):

A typical procedure is described here for the synthesis of a series of different aromatic aldehyde substituted quinoxaline thiosemicarbazide derivatives. In this step N'-(7-chloro-3-isopropyl-1H-quinoxaline-2-ylidine) thiosemicarbazide (IV) (0.01 mmol) was refluxed with different aromatic aldehydes (0.01 mol), in methanol (50 ml) and added glacial acetic acid (6-8 drops) for 4-5 hours. The progress of the reaction was monitored by TLC on silica-gel 60 plates until a distinct spot of the product was obtained. At the end of the reaction, the crude precipitate was filtered and recrystallized with methanol. The final product thus obtained was chromatographed on silica gel (60-120 mesh), using solvent system chloroform: methanol (3:1) as eluent to furnish pure compounds Va-Vf.

(1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene)-4-(1-(4-chlorophenyl) methylidene) thiosemicarbazide(Va):

Yield: 67.5 %; m.p.190-192 oC; Mol. Formula:C19H17Cl2N5S;Mol. Wt:418.34; IR (KBr, cm-1): 3215(N-H str.), 2933(C-H sp2 str. aromatic), 2875(C-H sp2 str. alkyl), 1599(C=N str.), 1572(C=C aromatic str.), 1337(CH (CH3)2 str.), 1235(C=S str.), 785(C-Cl str.), 1110,1057,1005( aromatic C-H in plane bending), 668,614,519( aromatic C-H out plane bending); 1H NMR (DMSO-d6): δ 10.89(s,1H, N-NH), 10.68(s,1H, NH), 9.15(s, 1H, N=CH), 7.28(s,2H, Ar. H), 7.24-7.27(d, 1H, Ar. H-8), 7.13-7.16(d, 1H, Ar. H-5), 7.01-7.04(d, 1H, ArH-6), 6.95-6.98(s,2H, Ar. H), 2.21-2.24(m, 1H, CH i-pr.), 1.95(s,6H,-(CH3)2); ESI-MASS: m/z [M+1]+ 419.07;Anal. Calculated. for C19H17Cl2N5S:C, 54.55; H, 4.10; N, 16.74; S, 7.66; Found: C, 54.52; H, 4.14; N, 16.73.

(1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene)-4-(1-(4-nitrophenyl) methylidene) thiosemicarbazide(Vb):

Yield: 68 %; m.p.197-200 oC; Mol. Formula:C19H17ClN6O2S;Mol. Wt:428.90; IR (KBr, cm-1): 3402(N-H str.), 2939(C-H sp2 str. aromatic), 2864(C-H sp2 str. alkyl), 1607(C=N str.), 1579(C=C aromatic str.), 1398(CH (CH3)2 str.), 1231 (C=S str.), 747 (C-Cl str.), 1147,1105,1054 ( aromatic C-H in plane bending), 850,668,610,560 ( aromatic C-H out plane bending); 1H NMR (DMSO-d6): δ 11.02 (s,1H, N-NH), 10.60 (s,1H, NH), 9.31 (s, 1H, N=CH), 7.86-7.89 (d,2H, Ar. H), 7.82-7.85 (d, 1H, Ar. H-8), 7.59-7.62 (d, 1H, Ar. H-5), 7.28-7.34 (d, 1H, Ar. H-6), 6.96-6.98 (d,2H, Ar. H), 2.17-2.23 (m, 1H, CH,i-pr.), 1.30 (s,6H,-(CH3)2); ESI-MASS: m/z [M+2]+ 430.15;Anal. Calculated. for C19H17ClN6O2S: C, 53.21; H, 4.00; N, 19.59; S, 7.46; Found: C, 53.24; H, 4.5; N, 19.56.

(1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene)-4-(1-(4-methoxyphenyl) methylidene) thiosemicarbazide(Vc):

Yield: 68.5 %; m.p.202-204oC; Mol. Formula:C20H20ClN5OS;Mol. Wt:413.92; IR (KBr, cm-1): 3380(N-H str.), 3236 (C-H sp2 str. aromatic), 3097 (C-H sp2 str. alkyl), 1611 (C=N str.), 1576 (C=C aromatic str.), 1394 (CH (CH3)2 str.), 1224(C=S str.), 779 (C-Cl str.), 1140,1052,979 ( aromatic C-H in plane bending), 904,668,556 ( aromatic C-H out plane bending); 1H NMR (DMSO-d6): δ 10.60 (s,1H, N-NH), 10.51(s,1H, NH), 9.05 (s, 1H, N=CH), 7.71-7.74 (d,2H, Ar. H), 7.50-7.53 (d, 1H, Ar. H-8), 7.28-7.35 (d, 1H, Ar. H-5), 6.94-6.97 (d, 1H, ArH-6), 6.72-6.76 (d,2H, Ar. H), 2.46-2.53 (m, 1H, CH,i-pr.), 1.56 (s, 3H, -OCH3), 1.22 (s,6H,-(CH3)2); ESI-MASS: m/z [M+1]+ 415.02;Anal. Calculated. for C20H20ClN5OS: C, 58.03; H, 4.87; N, 16.92; S, 7.75;Found: C, 58.07; H, 4.92; N, 16.88.

(1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene)-4-(1-(4-hydroxyphenyl) methylidene) thiosemicarbazide(Vd):

Yield: 70.5 %; m.p.195-197oC; Mol. Formula:C19H18ClN5OS;Mol. Wt:399.90; IR (KBr, cm-1):3430 (O-H str.), 3395 (N-H str.), 2924 (C-H sp2 str. aromatic), 2839 (C-H sp2 str. alkyl), 1601 (C=N str.), 1569 (C=C aromatic str.), 1372 (CH (CH3)2 str.), 1222 (C=S str.), 738 (C-Cl str.), 1145,1115,1044 ( aromatic C-H in plane bending), 843,657,602,548 ( aromatic C-H out plane bending); 1H NMR (DMSO-d6): δ 10.97 (s,1H, N-NH), 10.56 (s,1H, NH), 10.05 (s, 1H, OH), 9.67 (s, 1H, N=CH), 7.83-7.87 (d,2H, Ar. H), 7.71-7.74 (d, 1H, Ar. H-8), 7.49-7.52 (d, 1H, Ar. H-5), 7.25-7.31 (d, 1H, Ar. H-6), 6.91-6.96 (d,2H, Ar. H), 2.19-2.26 (m, 1H, CH,i-pr.), 1.28 (s,6H,-(CH3)2); ESI-MASS: m/z [M+2]+ 402.08;Anal. Calculated. for C19H18ClN5OS: C, 57.07; H, 4.54; N, 17.51; S,7.46; Found: C, 57.04; H, 4.57; N, 17.48.

(1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene)-4-(1-(4-methylphenyl) methylidene) thiosemicarbazide(Ve):

Yield: 62.3 %; m.p.188-190oC;Mol. Formula: C20H20ClN5S;Mol. Wt: 397.92;IR (KBr, cm-1): 3354 (N-H str.), 2945 (C-H sp2 str. aromatic), 2840 (C-H sp2 str. alkyl), 1625 (C=N str.), 1529 (C=C aromatic str.), 1343 (CH (CH3)2 str.), 1246 (C=S str.), 756 (C-Cl str.). 1173, 1044, 973 (aromatic C-H in plane bending), 835, 644, 593 (aromatic C-H out plane bending).1H NMR(DMSO-d6): δ 11.13 (s,1H, N-NH), 10.70 (s,1H, NH), 9.22 (s, 1H, N=CH), 7.40-7.43 (d,2H, Ar. H), 7.36-7.39 (d, 1H, ArH-8), 6.79-6.81 (d, 1H, ArH-5), 6.58-6.62 (d, 1H, ArH-6), 6.17-6.21 (d,2H, Ar. H), 2.61-2.69 (m, 1H, CH, i-pr.), 1.65 (s, 3H, -CH3), 1.27 (s,6H,-(CH3)2);ESI-MASS: m/z [M+1]+ 399.14;Anal. Calculated. for C20H20ClN5S: C, 60.37; H, 5.07; N, 17.60; S, 8.06;Found:C, 60.41; H, 5.11; N, 17.57.

(1E,4E)-1-(7-chloro-3-isopropylquinoxalin-2(1H)-ylidene)-4-(1-(4-isopropylphenyl) methylidene) thiosemicarbazide(Vf):

Yield: 69.5 %; m.p.210-212oC; Mol. Formula:C22H24ClN5S;Mol. Wt:425.98;IR (KBr, cm-1): 3316(NH str.), 2982 (C-H sp2 aromatic str.), 2808 (C-H sp2 aliphatic str.), 1668 (C=N aromatic str.), 1512 (C=C str.), 1372 (CH (CH3)2 str.), 1342 (C-N str.), 1272 (C=S str.), 789 (C-Cl str.), 1164,1069,978 (aromatic C-H in plane bending), 841,6,98,594 (aromatic C-H in out of plane bending).1H NMR (DMSO-d6):δ 11.15 (s,1H, N-NH), 10.35 (s,1H, NH), 8.61 (s, 1H, N=CH), 7.85-7.88 (d,2H, Ar. H), 7.43-7.47 (d, 1H, Ar. H-8), 7.25-7.25 (d, 1H, Ar. H-5), 6.97-7.01 (d, 1H, ArH-6), 6.71-6.75 (d,2H, Ar. H), 2.25-2.40(m, 2H, CH,i-pr.), 1.34 (s, 6H, (CH3)2 ), 1.30 (s,6H,-(CH3)2); ESI-MASS : m/z [M+1]+ 427.12 Anal. Calculated for C22H30ClN5S : C, 62.03; H, 5.68; N, 16.44; S, 7.53; Found: C, 62.06; H, 5.72; N, 16.41.


MicrobialStrains: All the synthesized compounds (Va-Vf), were evaluated in vitro for their antibacterial and antifungal activity against Gram-negative bacterial strains such as Klebsielapneumonie(ATCC 15380), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27893), Salmonella typhi (MTCC 3216), Helicobacter pylori (ATCC 26695) and Gram-positive bacterial strains such as Bacillus subtilis (ATCC 6633), Bacillus thuringiensis (MTCC 714), Staphylococcus aureus (ATCC 25323), methicillin-resistant Staphylococcus aureus (ATCC 3591). Fungal strains used were Penicillium chrysogenum(ATCC 11709), Aspergillus niger(ATCC 9029), Candida albicans (ATCC 90028).

Antimicrobial Assay Methodology: Antimicrobialevaluation of all the synthesized derivatives (Va-Vf), were assayed by using the agar dilution method to determine the minimum inhibitory concentrations (MICs).48. Ciprofloxacin (CFX) and Fluconazole (FCZ) were used as antibacterial and antifungal reference standards, respectively. The range of concentrations of synthesized agents being tested based on the two-fold dilution series (1 mg/L). The dilutions of the synthesized agents and reference drugs were prepared in Mueller-Hinton (MH) agar for bacteria and in Sabouraud dextrose agar for fungi. Each test derivatives (10 mg) were dissolved in 1mL of dimethyl sulfoxide (DMSO) and the solution was diluted with water (9ml). Two-fold dilutions were made with melted Mueller-Hinton and Sabouraud dextrose agar to obtained the necessary concentrations of 100, 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78, 0.39, 0.19, 0.098, 0.049,.0.025, 0.013 and 0.006 µg/ml. The microbial inoculums were prepared by emulsifying overnight colonies from Mueller-Hinton and Sabouraud dextrose agar media in 0.85% saline. The prepared inoculums suspension photometrically adjusted at 600 nm for a cell density comparable to approximately 0.5 McFarland standards (1.5×108 CFU/mL). The suspensions of microorganisms were diluted in 0.85% saline to give 107 CFU/mL for bacteria and 105 CFU/mL for fungi. The plate spot was inoculated with microbial suspensions about 1µl each and incubated at 35-370C for 18-19 hours for bacteria and 28-300C for 50-72 hours for fungi. The minimum inhibitory concentration was observed and determined.

Antibacterial and AntifungalStudy: The synthesized aromatic aldehydes substituted quinoxaline thiosemicarbazide derivatives (Va-Vf) were evaluated for their antibacterial and antifungal activity. Most of the compounds showed excellent to significant activity towards Gram-negative, Gram-positive bacterial and fungal strains. The minimum inhibitory concentration of more active compounds along with Ciprofloxacin ranges from 0.19 – 0.78 µg/ mL for bacteria and with Fluconazole ranges 0.78 – 3.12 µg/ mL for fungal strains. The results of the antibacterial and antifungal activity evaluation are summarized in Table 2.


Molecular DockingStudies: In today’s globalized world, the molecular docking technique is one of the largely acclaimed structure-based drug design approaches, widely used ever since the early 1980s.49To understand the binding interactions of all the synthesized derivatives were docked into the active site of E.coli DNA gyrase B kinase and E. coli Topoisomerase IV. Crystal structure model of the target (PDB: 1AJ6 and 1S14) were downloaded from worldwide protein data bank ( and molecular docking studies were performed using the Auto Dock Tool 1.5.6 (ADT) 2011 software (Molecular Graphic Laboratory, The Script Research Institute, U. S. A.), To analyze the docking result and execute the protocol, The Discovery Studio® v17.2.0.16349 software (Client, U. S. A), was employed.

Protein and ligand preparation: The Crystal structure model of the target E.coli DNA gyrase B (PDB code: 1AJ6) and E. Coli Topoisomerase IV ( PDB code: 1S14), with their native ligand novobiocin were downloaded from Protein Data  Bank and prepared by the multistep process through the protein preparation menu of the AutoDock (version 1.5.6). The ChemDraw® Ultra 8.0 (Cambridge soft, USA) software was used to draw the various chemical structures of the ligand molecules.

Active Site Prediction: The Sitemap applies theoretical methods and predicts the most accurate binding site. A receptor grid was generated via the selection of the grid box. The binding site was recognized by specifying the atoms of a co-crystallized ligand (novobiocin). The scores were then calculated as the free energy of binding (ΔGb) and the final ten highest-scoring poses (conformations) for each molecule along with their scores and binding energies (ΔGb) were collated into a database. The database file generated from the docking procedure was further analyzed, with the binding mode (interactions) of the highest ten conformations for each docked molecule in the active site visualized and studied with the help of the Discovery studio visualization window


Chemistry: A series of various benzaldehydes substituted quinoxaline thiosemicarbazide derivatives (Va-Vf) were synthesized with a good percentage yield as per scheme Figure 1.  Structure and physicochemical data of the final compounds represented in Table 1. The chemical structures of the compounds were confirmed by elemental analysis, IR, NMR & Mass spectroscopy.

The IR spectra of the compounds exhibit absorption bands due to OH, N-H, C-H, C=C, C=N, (CH (CH3)2, C=S and C-Cl stretching. The IR of synthesized compounds showed absorption bands near ranges 3215-3395 cm-1, 2932-3236cm-1 and 2839- 3097cm-1 correlated with N-H stretching, C-H sp2 aromatic stretching and C-H sp2 aliphatic stretching respectively.  Also, the stretching absorption bands near ranges 1599-1668 cm-1, 1337-1398cm-1 and 1222-1272cm-1 correlated with C=N, -CH(CH3)2, and C=S groups respectively. IR displayed a characteristic broad absorption band at 3430 cm-1 for the OH group in compound Vd. The 1H-NMR at 300 MHz, the solvent used DMSO-d6 of all the derivatives showed a sharp singlet peak near range δ 1.27-1.95 ppm indicated isopropyl CH3 (6H) protons and δ 8.61-9.67 ppm indicated protons of Schiff bridge (N=CH). Multiple peaks appeared in all compounds ranges between δ 2.17-2.64 due to protons of isopropyl C-H. A broad set of singlet and doublet peak ranges δ 6.62-7.82 correlated to quinoxaline moiety aromatic hydrogens and sharp singlet peak range between δ10.40-11.28 indicated hydrogens of N-H group. A sharp singlet peak in compound Vd at δ 10.05 indicated hydroxyl group (OH) proton. The mass spectrum analysis of the compounds displayed characteristic peaks normally with [M+1]+ value and [M+2]+ value in compound Vd. The elemental analysis outcomes of the compounds almost ranged within ± 0.4% of the calculated values.

antimicrobial activity: The synthesized derivatives exhibited significant activity against Gram-negative and Gram-positive bacteria when compared with standard Ciprofloxacin antibacterial drug (Table 2). The compound Vb showed more potent activity against Gram-negative strains. aeruginosa (0.39 µg/ mL) and H. pylori (0.39µg / mL) and equipotent activity against K. pneumonia (0.19 µg/ mL), E. coli (0.19 µg / mL), and less active against S. Typhi (0.19 µg/ mL).  The compound Vc exhibited good activity against H. pylori (0.39 µg / mL) but equipotent activity K. pneumoniae (0.19 µg/ mL), E. coli (0.19 µg / mL) and P. aeruginosa (0.78 µg/ mL). Whereas no compounds showed significant activity against S. typhi.

On the study of Gram-positive strains, a more excellent twofold activity was observed of compound Ve and Vf against B. subtilis (0.39 µg / mL), S. aureus (0.19 µg / mL)  and MRSA (0.78 µg / mL) and equipotent activity against B. thuringiensis (0.39 µg / mL). The compound Vcalso showed twofold activity against B. subtilis (0.39 µg / mL) and equipotent activity against B. thuringiensis (0.39 µg / mL) and MRSA (1.56 µg / mL). Thus, it was found that compound B exhibited more potent activity against Gram-negative bacterial strains but less active against Gram-positive bacterial strains whereas compound Ve and Vf showed more potent activity against Gram-positive bacterial strains rather than Gram-negative bacterial strains. The study revealed that the compound Vc showed good activity against some Gram-negative strains as well as some Gram-positive strains when compared with reference standard drug ciprofloxacin.

The study of antifungal activity was tested against strains such as P. Chrysogenum, A. niger and C. Albicans using fluconazole as a standard drug (Table 2). Compound Vc and Vf exhibit a twofold amplified activity against A. niger(3.12 µg / mL) and C. Albicans (1.56 µg / mL), whereas equipotent activity against P. Chrysogenum(0.78 µg / mL).The compound Ve exhibit equipotent activity against. Chrysogenum(0.78 µg / mL) and A. niger(6.25 µg / mL), but less active against C. Albicans (6.25 µg / mL). The overall study revealed that compound Vc, Vfand some extent compound Veexplored the best potential activity against fungal strains in comparison with that of the standard compounds.

Molecular docking results: The docking of ligand molecules within the active pocket site of E. coli DNA gyrase B revealed that all the inhibitor compounds were exhibited the bonding with no. of amino acids which are showed in Figure 2. Theoretically, all the synthesized compounds showed very good docking energy ranging from -8.0 to -8.3 kcal/mol for PDB:1AJ6 and -7.6 to -8.2 for PDB:1S14 (Table 3)

We concentrated our attention on the more potent compounds Vb, Vc, Ve and Vfembedded nicely within the active pocket of E. coli DNA gyrase B (PDB: 1AJ6) with the binding energy of -8.0, -8.0, -8.3 and -8.1 Kcal/mol respectively. The interactions of the compounds revealed that the methyl groups of isopropyl present on the quinoxaline ring was involved in hydrophobic interaction with ILE94 and VAL20 that may explain the observation that isopropyl substitution on the quinoxaline ring enhances E. Coli DNA gyrase B inhibitory potency. The quinoxaline ring displayed hydrophobic interaction (arene-cation interaction) with ASN46 and THR165. Furthermore, the secondary amine group of the thiosemicarbazide moiety showed hydrogen linkage with GLU50 and thio group linked with THR165 and GLY177. The nitro and methoxy group in compound Vb and Vc showed binding with VAL43, VAL71 and VAL 167 (Figure 2).

            The docking study of the synthesized compounds against E. coli Topoisomerase IV using PDB code: 1S14 reveals that all the compounds exhibited good binding energy ranging from -7.6 to -8.2 kcal/mol (Table 4). The more potent compound Vb showed good docking energy (-8.2 kcal/mol) and docked effectively in the active pocket site of E. coli Topoisomerase IV. The ligand-protein complexes showed that the quinoxaline ring of each compound binds extensively through hydrophobic interactions with GLU1046 and MET1074. The NH of the quinoxaline ring displayed hydrogen bond linkage with GLY1073. The nitrogen of thiosemicarbazide moiety exhibit hydrogen and hydrophobic linkage with ARG1132 and ARG1072(Figure 3).


In conclusion, the present research reports the successful synthesis of different benzaldehydes substituted (1E, 4E)-1-(7-chloro-3-isopropyl quinoxaline- 2(1H)-ylidene) thiosemicarbazide derivatives and their in-vitro antimicrobial evaluation with molecular docking studies. Most of the evaluated compounds showed slightly more significant antimicrobial activity in comparison to reference compound. The structure-activity relationship study affirmed that the substitution by para-nitro benzaldehyde (Vb) enhance the activity against Gram-negative bacteria whereas substitution by para-methyl benzaldehyde (Ve) and para-isopropyl benzaldehyde (Vf) enhance the spectrum of activity against Gram-positive bacteria as well as fungal strains. Substitution by para-methoxy benzaldehyde as in compound Vc enhances the spectrum of activity against both Gram-negative as well as Gram-positive bacterial strains and also against fungal strains in comparison to reference compound.

The electron-withdrawing and donating groups substituted in the para position of benzaldehydes exhibited well binding with amino acids in the active pocket site of DNA gyrase B and E. coli Topoisomerase IV. Thus, following this research, the synthesized molecules could be considered as candidates for more clinically relevant researches in the future to overcome this type of antimicrobial resistance.

ACKNOWLEDGMENTS: The authors are thankful to the authorities, Department of Pharmacy, Bhagwant University Ajmer, Rajasthan, India and Goel institute of pharmacy and Sciences, Lucknow, U.P., India, for providing facilities to perform the research work and also thankful to the Department of Biotechnology of Saroj Institute of Technology & Management, Lucknow, India for providing bacterial and fungal strains.

AUTHORS’ CONTRIBUTIONS: Girendra Kumar Gautam: provided the concept and design of the study, acquisition of data, analysis and interpretation of data. Akash Ved: provided methodology of study and help in the drafting of the manuscript. Krishna Kumar Varshney: helped in molecular modelling study and interpretation of data. All authors read and approved the final manuscript.

HUMAN AND ANIMAL RIGHTS: No human and animals were used for studies in the present research work.

CONFLICT OF INTEREST: The authors declare no conflict of interest, financial or otherwise.

SOURCE OF FUNDING: TheAuthor received no specific funding for this research work.



  1. El-Sharief MAMS, Abbas SY, El-Bayouki KAM, E. W. El-Gammal EW. Synthesis of thiosemicarbazones derived from N-(4-hippuric acid)thiosemicarbazide and different carbonyl compounds as antimicrobial agents.Eur J Med Chem. 2013; 67:263–68.

  2. Tenover FC.Mechanisms of antimicrobial resistance in bacteria. Am J Inf Cont. 2006; 34 Suppl 5:S3–S10.

  3. Katritzky AR, Rees CW, editors. The structure, reactions, synthesis, and uses of heterocyclic compounds.Comprehensive Heterocyclic Chemistry. 1st ed. Oxford UK: Pergamon Press;1984:157–97.

  4. Ganapaty S, Ramalingam P,Rao CB. Antibacterial, antifungal and antitubercular screening of some novel condensed bridgehead nitrogen heterocycles of quinoxalines. Ind J Hetero Chem. 2007; 16:283-86.

  5. Refaat HM, Moneer AA, Khalil OM. Synthesis and antimicrobial activity of certain novel quinoxalines. Arch Phram Res. 2004; 27:1093-98.

  6. Badran MM, Abouzid KAM, Hussein MHM. Synthesis of certain substituted quinoxalines as anti-microbial agents. Part II.Arch Pharm Res. 2003; 26:107–13.

  7. Tandon VK, Yadav DB, Maurya HK, Chaturvedi AK,Shukla PK. Design, synthesis and biological evaluation of 1,2,3- trisubstituted-1,4- dihydrobenzo [g] quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents. Bioorg Med Chem. 2006; 14(17):6120-126.

  8. Sanna P, Carta A, Loriga M, Zanetti S, Sechi L. Preparation and biological evaluation of 6/7-trifluoromethyl (nitro)-6,7-difluoro-3-alkyl(aryl)-substituted-quinoxalin-2-ones. Part III Farmaco. 1999; 54(3):1169-177.

  9. Jaso A, Zarranz B, Aldana I, Monge A. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives Asanti-mycobacterium tuberculosis agents. Eur J Med Chem. 2003; 38:791–800.

  10. Rangisetty JB, Gupta CNVHB, Prasad AL, Srinivas P, Sridhar N, Parimoo P, et al. Synthesis of new-arylamino quinoxalines and their antimalarial activity in mice. J Pharm Pharmacol. 2001; 53(10):1409–13.

  11. Crowther AF, Curd FHS, Davey DG, Stacey GJ. Synthetic antimalarials, Part 39 Dialkylaminoalkyl-aminoquinoxalines. J Chem Soc. 1949:1260–62.

  12. Guillon J, Forfar I, Matsuda MM, Desplat V, Saliege M, Thiolat D. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.Bioorg Med Chem Lett. 2007; 15:194-210.

  13. Carta A, Sanna P, Gherardini, Usai D, Zanetti S. Novel functionalized pyrido[2,3-9]-quinoxalinones as antibacterial, antifungal and anticancer agents. II Farmaco. 2001; 56(12):933–38.

  14. Sanna P, Carta A, Loriga M, Zanetti S, Sechi L. Synthesis of 3,6,7-substituted quinoxalin- 2-ones for evaluation of the antimicrobial and anticancer activity. Part: II Farmaco.1999; 54(3):161-68.

  15. Hassan SY, Khattab SN, BekhitAA, Amer A. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.Bioorg Med Chem Lett. 2006; 16(6):1753-56.

  16. Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK. 4- Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J Med Chem. 1990; 33(8):2240-54.

  17. Burguete A, Pontiki E, Hadjipavlou-Litina VD.Synthesis and anti-inflammatory/antioxidant activities of some new ring-substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.Bioorg Med Chem Lett. 2007; 17(23): 6439-43.

  18. Santivañez-Veliz M, Pérez-Silanes S, Torres E, Moreno-Viguri E. Hypoxia-Selective Agents Derived from Quinoxaline 1,4-Di-N-oxides. Bioorg Med Chem Lett. 2016; 26(9): 2188-93.

  19. Ries UJ, Priekpe HW, Havel NH, Handschuh S, Mihm G, Stassen JM, et al. Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as a novel, potent antithrombotic agents. Bioorg Med Chem Lett. 2003; 13:2297-02.

  20. Palluotto F, Sosic A, Pinato O, Zoidis G, Catto M, SissiC, et al.Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties. Eur J Med Chem. 2016; 123:704-717.

  21. Beraldo H, Gambino D. The wide pharmacological versatility of semi carbazones, thiosemicarba-zones and their metal complexes. Mini-Rev Med Chem. 2004;4(1):31–39.

  22. Ramachandran R, Rani M, Kabilan S. Design, synthesis and biological evaluation of novel 2-[(2, 4-diaryl-3-azabicyclo [3.3. 1] nonan-9-ylidene) hydrazono]-1, 3-thiazolidine-4-ones as a new class of antimicrobial agents. Bioorg Med Chem Lett. 2009; 19(10): 2819–23.

  23. Shipman Jr C, Smith SH, Drach JC, Klayman DL. Antiviral Activity of 2-Acetylpyridine Thiosemicarbazones Against Herpes Simplex Virus. Antimic Agen Chem. 1981; 19(4):682-85.

  24. Quenelle DC, Keith KA, Kern ER. In-vitro and in-vivo evaluation of isatin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiv Res. 2006;71(1):24–30. 

  25. Afrasiabi Z, Sinn E, Padhye S. Transition metal complexes of phenanthrenequinone thiosemicarbazone as potential anticancer agents: synthesis, structure, spectroscopy, electrochemistry and in-vitro anticancer activity against human breast cancer cell-line, T47D. J Inorg Biochem.  2003;95(4):306–14. 

  26. Singh N, Srivastava A, Sodhi A, Ranjan P. In- vitro and in- vivo antitumor studies of a new thiosemicarbazide derivative and its complexes with 3d-metal ions. Trans Met Chem 2000;25:133–40. 

  27. Yousef TA, Badria FA, Ghazy SE, El-Gammal OA, Abu El-Reash GM. In-vitro and in-vivo antitumor activity of some synthesized 4-(2-pyridyl)-3-Thiosemicarbazides derivatives. Inter J Med Sci.  2011;3(2):37–46. 

  28. Singh S, Bharti N, Naqvi F, Azam A. Synthesis, characterization and in-vitro antiamoebic activity of 5 nitrothiophene-2-carboxaldehyde thiosemicarbazones and their Palladium(II) and Ruthenium(II) complexes. Eur J Med Chem. 2004;39(5):459–65. 

  29. Sharma S, Athar F, Maurya MR, Naqvi F, Azam A. Novel bidentate complexes of Cu (II) derived from 5-nitrofuran-2-carboxaldehyde thiosemicarbazones with antiamoebic activity against E. histolytica. Eur J Med Chem. 2005;40(12):557–62. 

  30. Illan-Cabeza NA, Hueso-Urena F, Moreno-Carretero MN, MartinezMartos JM, Ramirez-Exposito MJ. Synthesis, Characterization and Antiproliferative Activity of Metal Complexes with the Schiff Base Derived from the Condensation 1:2 of 2,6-Diformyl-4- Methylphenol and 5,6-Diamino-1,3-Dimethyluracil. J InorgBiochem. 2008; 102:647–55.

  31. Naveen VK, Vidyanand KR, Kirasur BN. Mallinath HH. Transition metal complexes of thiosemicarbazones with quinoxaline hub: an emphasis on antidiabetic property. Med Chem Res. 2012; 21(5):663–71.

  32. Bal TR, AnandB, Yogeeswari P, Sriram D. Synthesis and evaluation of the anti-HIV activity of isatin beta-thiosemicarbazone derivatives. Bioorg Med Chem Lett. 2005; 15 (20):4451-55.

  33. Ukrainets IV, Tkach AA, Grinevich LA, Turov AV, Bevz OV. 4-Hydroxy-2-quinolones 165.1-R-4-hydroxy-2-oxo-1,2-dihydro-quinoline-3-carbaldehydes and their thiosemicarbazones, Synthesis, structure, and biological properties. Chem Hetero Comp. 2009; 45:705–14.

  34. Mohamed NA, Mohamed RR, Seoudi RS. Synthesis and characterization of some novel antimicrobial thiosemicarbazone O-carboxymethyl chitosan derivatives. Int J BioMacromol. 2014; 63:163–69.

  35. Siddiqui N, Singh O. Antibacterial activity of some 4-N-substituted thiosemicarbazides and thiosemicarbazones. Ind J Pharm Sci. 2003; 65(4):423-25.

  36. Parul N, Subhangkar N, Arun M. Antimicrobial activity of different thiosemicarbazone compounds against microbial pathogens. Int Res J Pharm. 2013; 3(5):351–63.

  37. Siwek A, Stefanska J, Dzitko K, Ruszezak A. Antifungal effect of 4-arylthio semicarbazides against Candida species. Search for the molecular basis of antifungal activity of thiosemicarbazide derivatives. J Mol Model. 2012; 18(9):4159-70.

  38. Naeem A, Badshah SL, Muska M, Ahmad N. Khan K. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity. Molecules. 2016; 21(4):268.

  39. Esteves-Souza A. Rodrigues-Santos CE, Del Cistia CN, Silva DR, Sant’anna CM, Echevarria A. Solvent-free synthesis, DNA-topoisomerase II activity and molecular docking study of new asymmetrically N, N’-substituted ureas. Molecules. 2012; 17: 12882–94.

  40. Tanitame A, Oyamada Y, Ofuji K, Fujimoto M, Suzuki K, Ueda T, Terauchi H, Kawasaki M, et al. Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring. Bioorg Med Chem. 2004; 12(21):5515–24.

  41. Azimvand J. Synthesis of new triazole and oxadiazole containing compound in the azide reaction as an antibacterial drug.J Chem Pharma Res. 2012; 4(8):3900-04.

  42. Efthimiou EK, Thomadaki H, Sanakis Y, Raptopoulou CP, Katsaros N, Scorilas A, et al. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,20 -bipyridine. J InorgBiochem. 2007; 101:64–73.

  43. El Shehry MF, Ghorab MM, Abbas SY, Fayed EA, Shedid SA, Ammar YA. Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents. Eur J Med Chem. 2017; 143:1463–73.

  44. Paneth A, Staczek P, Plech T, Dzitko K, Wujec M, Kusmierz E, et al. Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerase inhibitors. J EnzymInhib Med Chem. 2016;31:14-22.

  45. Siwek A, Staczek P, Wujec M, Stefanska J, Kosikowska U, Malm A, et al. Biological and docking studies of topoisomerase IV inhibition of thiosemicarbazides. J Mol Model.2011; 17:2297-03.

  46. Mohi El-Deen EM, Abd El-Meguid EA, Hasabelnaby S, Karam EA, Nossier ES. Synthesis, docking studies and in vitro evaluation of some novel theinopyridines and fused theinopyridine-quinolines as antibacterial agents and DNA gyrase inhibitors. Molecules.2019; 24(20):36-50.

  47. Bellon S, Parsons JD, Wei Y, Hayakawa K, Swenson LL, Charifson PS, et al. Crystal structure of E. coli topoisomerase IV ParE subunit (24 and 43 kilodalton): A single residue decades differences in novobiocin in potency against topoisomerase IV and DNA gyrase.Antimicrob Agents Chemot. 2004; 48(5):1856-64.

  48. European Committee for antimicrobial susceptibility testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microb Infect. 2000; 6(9):509-515.


Dr. Pramod Kumar Manjhi joined Editor-in-Chief since July 2021 onwards

COPE guidelines for Reviewers

SCOPUS indexing: 2014, 2019 to 2021

Awards, Research and Publication incentive Schemes by IJCRR

Best Article Award: 

One article from every issue is selected for the ‘Best Article Award’. Authors of selected ‘Best Article’ are rewarded with a certificate. IJCRR Editorial Board members select one ‘Best Article’ from the published issue based on originality, novelty, social usefulness of the work. The corresponding author of selected ‘Best Article Award’ is communicated and information of award is displayed on IJCRR’s website. Drop a mail to for more details.

Women Researcher Award:

This award is instituted to encourage women researchers to publish her work in IJCRR. Women researcher, who intends to publish her research work in IJCRR as the first author is eligible to apply for this award. Editorial Board members decide on the selection of women researchers based on the originality, novelty, and social contribution of the research work. The corresponding author of the selected manuscript is communicated and information is displayed on IJCRR’s website. Under this award selected women, the author is eligible for publication incentives. Drop a mail to for more details.

Emerging Researcher Award:

‘Emerging Researcher Award’ is instituted to encourage student researchers to publish their work in IJCRR. Student researchers, who intend to publish their research or review work in IJCRR as the first author are eligible to apply for this award. Editorial Board members decide on the selection of student researchers for the said award based on originality, novelty, and social applicability of the research work. Under this award selected student researcher is eligible for publication incentives. Drop a mail to for more details.

Best Article Award

A Study by Humaira Tahir et al. entitled "Comparison of First Analgesic Demand after Major Surgeries of Obstetrics and Gynecology between Pre-Emptive Versus Intra-Operative Groups by Using Intravenous Paracetamol: A Cross-Sectional Study" is awarded Best Article for Vol 14 issue 14
A Study by Monica K. entitled "Risk Predictors for Lymphoma Development in Sjogren Syndrome - A Systematic Review" is awarded Best Article for Vol 14 issue 13
A Study by Mokhtar M Sh et al. entitled "Prevalence of Hospital Mortality of Critically Ill Elderly Patients" is awarded Best Article for Vol 14 issue 12
A Study by Vidya S. Bhat et al. entitled "Effect of an Indigenous Cleanser on the Microbial Biofilm on Acrylic Denture Base - A Pilot Study" is awarded Best Article for Vol 14 issue 11
A Study by Pandya S. et al. entitled "Acute and 28-Day Repeated Dose Subacute Toxicological Evaluation of Coroprotect Tablet in Rodents" is awarded Best Article for Vol 14 issue 10
A Study by Muhammad Zaki et al. entitled "Effect of Hemoglobin Level on the Severity of Acute Bronchiolitis in Children: A Case-Control Study" is awarded Best Article for Vol 14 issue 09
A Study by Vinita S & Ayushi S entitled "Role of Colour Doppler and Transvaginal Sonography for diagnosis of endometrial pathology in women presenting with Abnormal Uterine Bleeding" is awarded Best Article for Vol 14 issue 08
A Study by Prabhu A et al. entitled "Awareness of Common Eye Conditions among the ASHA (Accredited Social Health Activist) Workers in the Rural Communities of Udupi District- A Pilot Study" is awarded Best Article for Vol 14 issue 07
A Study by Divya MP et al. entitled "Non-Echoplanar Diffusion-Weighted Imaging and 3D Fiesta Magnetic Resonance Imaging Sequences with High Resolution Computed Tomography Temporal Bone in Assessment and Predicting the Outcome of Chronic Suppurative Otitis Media with Cholesteatoma" is awarded Best Article for Vol 14 issue 06
A Study by Zahoor Illahi Soomro et al. entitled "Functional Outcomes of Fracture Distal Radius after Fixation with Two Different Plates: A Retrospective Comparative Study" is awarded Best Article for Vol 14 issue 05
A Study by Ajai KG & Athira KN entitled "Patients’ Gratification Towards Service Delivery Among Government Hospitals with Particular Orientation Towards Primary Health Centres" is awarded Best Article for Vol 14 issue 04
A Study by Mbungu Mulaila AP et al. entitled "Ovarian Pregnancy in Kindu City, D.R. Congo - A Case Report" is awarded Best Article for Vol 14 issue 03
A Study by Maryam MJ et al. entitled "Evaluation Serum Chemerin and Visfatin Levels with Rheumatoid Arthritis: Possible Diagnostic Biomarkers" is awarded Best Article for Vol 14 issue 02
A Study by Shanthan KR et al. entitled "Comparison of Ultrasound Guided Versus Nerve Stimulator Guided Technique of Supraclavicular Brachial Plexus Block in Patients Undergoing Upper Limb Surgeries" is awarded Best Article for Vol 14 issue 01
A Study by Amol Sanap et al. entitled "The Outcome of Coxofemoral Bypass Using Cemented Bipolar Hemiarthroplasty in the Treatment of Unstable Intertrochanteric Fracture of Femur in a Rural Setup" is awarded Best Article Award of Vol 13 issue 24
A Study by Manoj KP et al. entitled "A Randomized Comparative Clinical Trial to Know the Efficacy of Ultrasound-Guided Transversus Abdominis Plane Block Against Multimodal Analgesia for Postoperative Analgesia Following Caesarean Section" is awarded Best Article Award of Vol 13 issue 23
A Study by Karimova II et al. entitled "Changes in the Activity of Intestinal Carbohydrases in Alloxan-Induced Diabetic Rats and Their Correction with Prenalon" is awarded Best Article of Vol 13 issue 22
A Study by Ashish B Roge et al. entitled "Development, Validation of RP-HPLC Method and GC MS Analysis of Desloratadine HCL and It’s Degradation Products" is awarded Best Article of Vol 13 issue 21
A Study by Isha Gaurav et al. entitled "Association of ABO Blood Group with Oral Cancer and Precancer – A Case-control Study" is awarded Best Article for Vol 13 issue 20
A Study by Amr Y. Zakaria et al. entitled "Single Nucleotide Polymorphisms of ATP-Binding Cassette Gene(ABCC3 rs4793665) affect High Dose Methotrexate-Induced Nephrotoxicity in Children with Osteosarcoma" is awarded Best Article for Vol 13 issue 19
A Study by Kholis Ernawati et al. entitled "The Utilization of Mobile-Based Information Technology in the Management of Dengue Fever in the Community Year 2019-2020: Systematic Review" is awarded Best Article for Vol 13 issue 18
A Study by Bhat Asifa et al. entitled "Efficacy of Modified Carbapenem Inactivation Method for Carbapenemase Detection and Comparative Evaluation with Polymerase Chain Reaction for the Identification of Carbapenemase Producing Klebsiella pneumonia Isolates" is awarded Best Article for Vol 13 issue 17
A Study by Gupta R. et al. entitled "A Clinical Study of Paediatric Tracheostomy: Our Experience in a Tertiary Care Hospital in North India" is awarded Best Article for Vol 13 issue 16
A Study by Chandran Anand et al. entitled "A Prospective Study on Assessment of Quality of Life of Patients Receiving Sorafenib for Hepatocellular Carcinoma" is awarded Best article for Vol 13 issue 15
A Study by Rosa PS et al. entitled "Emotional State Due to the Covid – 19 Pandemic in People Residing in a Vulnerable Area in North Lima" is awarded Best Article for Vol 13 issue 14
A Study by Suvarna Sunder J et al. entitled "Endodontic Revascularization of Necrotic Permanent Anterior Tooth with Platelet Rich Fibrin, Platelet Rich Plasma, and Blood Clot - A Comparative Study" is awarded Best Article for Vol 13 issue 13
A Study by Mona Isam Eldin Osman et al. entitled "Psychological Impact and Risk Factors of Sexual Abuse on Sudanese Children in Khartoum State" is awarded Best Article for Vol 13 issue 12
A Study by Khaw Ming Sheng & Sathiapriya Ramiah entitled "Web Based Suicide Prevention Application for Patients Suffering from Depression" is awarded Best Article for Vol 13 issue 11
A Study by Purushottam S. G. et al. entitled "Development of Fenofibrate Solid Dispersions for the Plausible Aqueous Solubility Augmentation of this BCS Class-II Drug" is awarded Best article for Vol 13 issue 10
A Study by Kumar S. et al. entitled "A Study on Clinical Spectrum, Laboratory Profile, Complications and Outcome of Pediatric Scrub Typhus Patients Admitted to an Intensive Care Unit from a Tertiary Care Hospital from Eastern India" is awarded Best Article for Vol 13 issue 09
A Study by Mardhiah Kamaruddin et al. entitled "The Pattern of Creatinine Clearance in Gestational and Chronic Hypertension Women from the Third Trimester to 12 Weeks Postpartum" is awarded Best Article for Vol 13 issue 08
A Study by Sarmila G. B. et al. entitled "Study to Compare the Efficacy of Orally Administered Melatonin and Clonidine for Attenuation of Hemodynamic Response During Laryngoscopy and Endotracheal Intubation in Gastrointestinal Surgeries" is awarded Best Article for Vol 13 issue 07
A Study by M. Muthu Uma Maheswari et al. entitled "A Study on C-reactive Protein and Liver Function Tests in Laboratory RT-PCR Positive Covid-19 Patients in a Tertiary Care Centre – A Retrospective Study" is awarded Best Article of Vol 13 issue 06 Special issue Modern approaches for diagnosis of COVID-19 and current status of awareness
A Study by Gainneos PD et al. entitled "A Comparative Evaluation of the Levels of Salivary IgA in HIV Affected Children and the Children of the General Population within the Age Group of 9 – 12 Years – A Cross-Sectional Study" is awarded Best Article of Vol 13 issue 05 Special issue on Recent Advances in Dentistry for better Oral Health
A Study by Alkhansa Mahmoud et al. entitled "mRNA Expression of Somatostatin Receptors (1-5) in MCF7 and MDA-MB231 Breast Cancer Cells" is awarded Best Article of Vol 13 issue 06
A Study by Chen YY and Ghazali SRB entitled "Lifetime Trauma, posttraumatic stress disorder Symptoms and Early Adolescence Risk Factors for Poor Physical Health Outcome Among Malaysian Adolescents" is awarded Best Article of Vol 13 issue 04 Special issue on Current Updates in Plant Biology to Medicine to Healthcare Awareness in Malaysia
A Study by Kumari PM et al. entitled "Study to Evaluate the Adverse Drug Reactions in a Tertiary Care Teaching Hospital in Tamilnadu - A Cross-Sectional Study" is awarded Best Article for Vol 13 issue 05
A Study by Anu et al. entitled "Effectiveness of Cytological Scoring Systems for Evaluation of Breast Lesion Cytology with its Histopathological Correlation" is awarded Best Article of Vol 13 issue 04
A Study by Sharipov R. Kh. et al. entitled "Interaction of Correction of Lipid Peroxidation Disorders with Oxibral" is awarded Best Article of Vol 13 issue 03
A Study by Tarek Elwakil et al. entitled "Led Light Photobiomodulation Effect on Wound Healing Combined with Phenytoin in Mice Model" is awarded Best Article of Vol 13 issue 02
A Study by Mohita Ray et al. entitled "Accuracy of Intra-Operative Frozen Section Consultation of Gastrointestinal Biopsy Samples in Correlation with the Final Histopathological Diagnosis" is awarded Best Article for Vol 13 issue 01
A Study by Badritdinova MN et al. entitled "Peculiarities of a Pain in Patients with Ischemic Heart Disease in the Presence of Individual Combines of the Metabolic Syndrome" is awarded Best Article for Vol 12 issue 24
A Study by Sindhu Priya E S et al. entitled "Neuroprotective activity of Pyrazolone Derivatives Against Paraquat-induced Oxidative Stress and Locomotor Impairment in Drosophila melanogaster" is awarded Best Article for Vol 12 issue 23
A Study by Habiba Suhail et al. entitled "Effect of Majoon Murmakki in Dysmenorrhoea (Usre Tams): A Standard Controlled Clinical Study" is awarded Best Article for Vol 12 issue 22
A Study by Ghaffar UB et al. entitled "Correlation between Height and Foot Length in Saudi Population in Majmaah, Saudi Arabia" is awarded Best Article for Vol 12 issue 21
A Study by Siti Sarah Binti Maidin entitled "Sleep Well: Mobile Application to Address Sleeping Problems" is awarded Best Article for Vol 12 issue 20
A Study by Avijit Singh"Comparison of Post Operative Clinical Outcomes Between “Made in India” TTK Chitra Mechanical Heart Valve Versus St Jude Mechanical Heart Valve in Valve Replacement Surgery" is awarded Best Article for Vol 12 issue 19
A Study by Sonali Banerjee and Mary Mathews N. entitled "Exploring Quality of Life and Perceived Experiences Among Couples Undergoing Fertility Treatment in Western India: A Mixed Methodology" is awarded Best Article for Vol 12 issue 18
A Study by Jabbar Desai et al. entitled "Prevalence of Obstructive Airway Disease in Patients with Ischemic Heart Disease and Hypertension" is awarded Best Article for Vol 12 issue 17
A Study by Juna Byun et al. entitled "Study on Difference in Coronavirus-19 Related Anxiety between Face-to-face and Non-face-to-face Classes among University Students in South Korea" is awarded Best Article for Vol 12 issue 16
A Study by Sudha Ramachandra & Vinay Chavan entitled "Enhanced-Hybrid-Age Layered Population Structure (E-Hybrid-ALPS): A Genetic Algorithm with Adaptive Crossover for Molecular Docking Studies of Drug Discovery Process" is awarded Best article for Vol 12 issue 15
A Study by Varsha M. Shindhe et al. entitled "A Study on Effect of Smokeless Tobacco on Pulmonary Function Tests in Class IV Workers of USM-KLE (Universiti Sains Malaysia-Karnataka Lingayat Education Society) International Medical Programme, Belagavi" is awarded Best article of Vol 12 issue 14, July 2020
A study by Amruta Choudhary et al. entitled "Family Planning Knowledge, Attitude and Practice Among Women of Reproductive Age from Rural Area of Central India" is awarded Best Article for special issue "Modern Therapeutics Applications"
A study by Raunak Das entitled "Study of Cardiovascular Dysfunctions in Interstitial Lung Diseas epatients by Correlating the Levels of Serum NT PRO BNP and Microalbuminuria (Biomarkers of Cardiovascular Dysfunction) with Echocardiographic, Bronchoscopic and HighResolution Computed Tomography Findings of These ILD Patients" is awarded Best Article of Vol 12 issue 13 
A Study by Kannamani Ramasamy et al. entitled "COVID-19 Situation at Chennai City – Forecasting for the Better Pandemic Management" is awarded best article for  Vol 12 issue 12
A Study by Muhammet Lutfi SELCUK and Fatma entitled "Distinction of Gray and White Matter for Some Histological Staining Methods in New Zealand Rabbit's Brain" is awarded best article for  Vol 12 issue 11
A Study by Anamul Haq et al. entitled "Etiology of Abnormal Uterine Bleeding in Adolescents – Emphasis Upon Polycystic Ovarian Syndrome" is awarded best article for  Vol 12 issue 10
A Study by entitled "Estimation of Reference Interval of Serum Progesterone During Three Trimesters of Normal Pregnancy in a Tertiary Care Hospital of Kolkata" is awarded best article for  Vol 12 issue 09
A Study by Ilona Gracie De Souza & Pavan Kumar G. entitled "Effect of Releasing Myofascial Chain in Patients with Patellofemoral Pain Syndrome - A Randomized Clinical Trial" is awarded best article for  Vol 12 issue 08
A Study by Virendra Atam et. al. entitled "Clinical Profile and Short - Term Mortality Predictors in Acute Stroke with Emphasis on Stress Hyperglycemia and THRIVE Score : An Observational Study" is awarded best article for  Vol 12 issue 07
A Study by K. Krupashree et. al. entitled "Protective Effects of Picrorhizakurroa Against Fumonisin B1 Induced Hepatotoxicity in Mice" is awarded best article for issue Vol 10 issue 20
A study by Mithun K.P. et al "Larvicidal Activity of Crude Solanum Nigrum Leaf and Berries Extract Against Dengue Vector-Aedesaegypti" is awarded Best Article for Vol 10 issue 14 of IJCRR
A study by Asha Menon "Women in Child Care and Early Education: Truly Nontraditional Work" is awarded Best Article for Vol 10 issue 13
A study by Deep J. M. "Prevalence of Molar-Incisor Hypomineralization in 7-13 Years Old Children of Biratnagar, Nepal: A Cross Sectional Study" is awarded Best Article for Vol 10 issue 11 of IJCRR
A review by Chitra et al to analyse relation between Obesity and Type 2 diabetes is awarded 'Best Article' for Vol 10 issue 10 by IJCRR. 
A study by Karanpreet et al "Pregnancy Induced Hypertension: A Study on Its Multisystem Involvement" is given Best Paper Award for Vol 10 issue 09

List of Awardees

A Study by Ese Anibor et al. "Evaluation of Temporomandibular Joint Disorders Among Delta State University Students in Abraka, Nigeria" from Vol 13 issue 16 received Emerging Researcher Award

A Study by Alkhansa Mahmoud et al. entitled "mRNA Expression of Somatostatin Receptors (1-5) in MCF7 and MDA-MB231 Breast Cancer Cells" from Vol 13 issue 06 received Emerging Researcher Award

RSS feed

Indexed and Abstracted in

Antiplagiarism Policy: IJCRR strongly condemn and discourage practice of plagiarism. All received manuscripts have to pass through "Plagiarism Detection Software" test before Toto Macau forwarding for peer review. We consider "Plagiarism is a crime"

IJCRR Code of Conduct: To achieve a high standard of publication, we adopt Good Publishing Practices (updated in 2022) which are inspired by guidelines provided by Committee on Publication Ethics (COPE), Open Access Scholarly Publishers Association (OASPA) and International Committee of Medical Journal Editors (ICMJE)

Disclaimer: International Journal of Current Research and Review (IJCRR) provides platform for researchers to publish and discuss their original research and review work. IJCRR can not be held responsible for views, opinions and written statements of researchers published in this journal.


International Journal of Current Research and Review (IJCRR) provides platform for researchers to publish and discuss their original research and review work. IJCRR can not be held responsible for views, opinions and written statements of researchers published in this journal


148, IMSR Building, Ayurvedic Layout,
        Near NIT Complex, Sakkardara,
        Nagpur-24, Maharashtra State, India

Copyright © 2022 IJCRR. Specialized online journals by ubijournal .Website by Ubitech solutions